Solving The Unsolved
Innovations for Safe & Affordable Genetic Medicine
We are committed to driving transformative innovations that redefine the development of genetic medicines. Our goal is to make advanced genetic therapies more accessible and affordable, particularly for underserved patients with rare diseases, ensuring broader access to life-changing treatments.
- Best-in-class, AAV-based gene therapy innovations.
- First-in-class, cell-derived nanovesicle-based gene delivery platform.
- Target-specific precision gene modulation, resulting in highly efficient gene delivery.
- Rapid disease modeling using human iPSCs.
- Rapid screening of drug safety, efficacy, and potency using 3D human cell models & organ-on-chips.
- Rapid IND enabling studies facilitating fast-track drug designation by FDA
- Small footprint, modular cell and vector production, yielding low COGS.
- Hassle-free, continuous scale-out from lab to commercial production, accelerating clinical trials and time-to-market
We are a team of world-class experts in the science and clinical development of genetic medicines. We aim to forge scientific talents and pharma networks of U.S. partners and robust R&D capabilities and biopharma infrastructure of Korea to accelerate the development and shorten the time-to-market of genetic medicine from lab to patients.
For any inquiries related to investment, collaboration, or other business matters, please don't hesitate to reach out to us.
Copyright © 2024 SolveX Bio - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.